Actively Recruiting
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-01-20
72
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
Sponsors
I
Icahn School of Medicine at Mount Sinai
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Psychosis typically emerges during late adolescence or early adulthood, significantly impacting long-term functioning. While CHR programs have the potential to reduce illness severity, individuals often face barriers such as stigma and limited access to services. Telehealth interventions could address these barriers and improve treatment accessibility and engagement. The study will focus on Group and Family-Based Cognitive Behavioral Therapy, Family-Based CBT, and individual CBT, adapted for telehealth delivery (GF-CBT-TH, F-CBT-TH, and I-CBT-TH). Participants aged 14-25 who meet CHR criteria will be randomly assigned to one of these interventions. Feasibility will be measured by recruitment rate, attendance, and retention. The study will assess the impact of the interventions on cognitive biases, social connectedness, family emotional climate, and proficiency in CBT skills. The three intervention groups will be compared in terms of psychosocial functioning, symptom severity, rates of remission from CHR, and rates of transition to psychosis. Additionally, factors like patient treatment preference, family emotional climate, and sociodemographic factors will be explored as potential moderators of treatment outcomes. Qualitative interviews will be conducted with participants and clinicians to inform dissemination efforts.
CONDITIONS
Official Title
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 14-25
- Ability to participate in assessments and treatment in English
- Meets criteria for psychosis-risk on SIPS
- Stable on medications with no changes within 1 month prior to enrollment
- Has a family member, blood relative, spouse, significant other, or close friend with more than 4 hours per week contact willing to participate
You will not qualify if you...
- Intellectual disability with IQ less than 70
- Medical conditions known to cause psychosis
- Moderate or severe substance use disorder with active use within the past 30 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
Y
Yulia Landa, PsyD, MS
CONTACT
R
Rachel Jespersen, LMSW
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here